CeNeRx BioPharma Awarded New Patent for Its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors.
By Avoiding the CNS, These Compounds May Be Free of the Side Effects Associated with Traditional Cannabinoid Compounds
.
Read more...